---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-023918"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2024-03-01T23:59:59+00:00"
generated_at: "2026-06-05T05:21:33.638874+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lyra Therapeutics doubles Executive Chair salary to $400k retroactive to Jan 1, 2024

## Summary
- Board approved salary increase for Executive Chair Harlan Waksal from $200k to $400k annually.
- Increase is retroactive to January 1, 2024.
- No other compensation changes for officers were disclosed in the filing.

## SEC filing metadata
- accession: 0000950170-24-023918
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2024-03-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000095017024023918/0000950170-24-023918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000095017024023918/lyra-20240226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-023918
- JSON: https://secwatch.observer/filing/0000950170-24-023918.json
- Plain text: https://secwatch.observer/filing/0000950170-24-023918.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.